Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
47.6M
Number of holders
38
Total 13F shares, excl. options
23.1M
Shares change
+2.22M
Total reported value, excl. options
$274M
Value change
+$29M
Number of buys
18
Number of sells
-11
Price
$11.93

Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2020

40 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q4 2020.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23.1M shares of 47.6M outstanding shares and own 48.57% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.71M shares), Blackstone Group Inc. (3.57M shares), Avidity Partners Management LP (2.56M shares), Soleus Capital Management, L.P. (2.38M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.34M shares), Vivo Capital, LLC (1.89M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.05M shares), Omega Fund Management, LLC (706K shares), Logos Global Management LP (550K shares), and JANUS HENDERSON GROUP PLC (509K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.